2012 HSR&D/QUERI National Conference Abstract
2032 — Genomics Research-Operations Partnerships in VHA
Scheuner MT, VA Greater Los Angeles HCS; Meyer L, National Director, Genomic Medicine Service; Lerner B, HSR&D Center of Excellence Boston VA HCS; Provenzale D, Durham VAMC; Yano E, VA Greater Los Angeles HCS;
To describe the background, motivation, characteristics, and accomplishments of four examples of productive partnerships between VHA health services genomics researchers and the National Genomic Medicine Service.
The workshop will feature presentations from the research and operations leaders from the new National Genomic Medicine Service. The first example is a partnership between VHA’s National Genomic Medicine Service and investigators who are conducting research that will help define quality indicators for genetic services provided in VA. Interviews and focus groups with both providers ordering genetic tests for Veterans and Veterans who have used these services have identified process and outcome measures of particular significance to VA. The measurement tools that will result from this study will be used to compare genomic delivery models and identify high-quality delivery of genomics healthcare. The second example is an ongoing national VA survey of clinical chiefs from various specialties that is inquiring about facility arrangements for clinical genetic services at each facility, including genetic testing and genetic consultative services. The goal of this proposal is to understand the organizational-level needs relating to the delivery of genomic medicine within VA now and in the near future. The third example is a joint proposal with the Genomic Medicine Service in Patient Care Services and researchers at the Durham VAMC to evaluate a data collection and decision support tool that assists clinic providers with disease-risk stratification and guides preventive healthcare strategies based on family history. A fourth example will describe preliminary findings of a QUERI rapid response project that is investigating the facilitators and barriers to implementation of screening for Lynch syndrome in VISN 22. Lynch syndrome is the most common form of hereditary colon cancer, and is one of the genetic screening programs that will be rolled out across VA nationally. The goal of each project is to help inform policy development and strategic planning of the national Genomic Medicine Service. The presentations will offer insights on how researchers and operational partners can engage one another, leverage opportunities of the relationships, and resolve challenges to partnerships striving to develop generalizable knowledge and guide implementation.
All HSR&D and QUERI researchers interested in exploring innovative approaches for conducting collaborative, partnered research.
Assumed Audience Familiarity with Topic: